Portal de Periódicos da CAPES

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak

2015; Centers for Disease Control and Prevention; Volume: 22; Issue: 2 Linguagem: Inglês

10.3201/eid2202.151656

1080-6059

Emmie de Wit, Darryl Falzarano, Clayton Onyango, Kyle Rosenke, Andrea Marzi, Melvin Ochieng, Bonventure Juma, Robert J. Fischer, Joseph Prescott, David Safronetz, Victor Omballa, D. Collins Owuor, Thomas Hoenen, Allison Groseth, Neeltje van Doremalen, Galina E. Zemtsova, Joshua Self, Trenton Bushmaker, Kristin L. McNally, Thomas Rowe, Shannon Emery, Friederike Feldmann, Brandi N. Williamson, Tolbert Nyenswah, Allen Grolla, James E. Strong, Gary Wong, Ute Ströeher, Mark A. Rayfield, Fatorma K. Bolay, Kathryn C. Zoon, Jorgen Stassijns, Livia Tampellini, Martin De Smet, Stuart T. Nichol, Barry S. Fields, Armand Sprecher, Heinz Feldmann, Moses Massaquoi, Vincent J. Munster,

COVID-19 epidemiological studies

Abstract Malaria is a major public health concern in the countries affected by the Ebola virus disease epidemic in West Africa. We determined the feasibility of using molecular malaria diagnostics during an Ebola virus disease outbreak and report the incidence of Plasmodium spp. parasitemia in persons with suspected Ebola virus infection.